Skip to main content

Table 3 Results of serum acylcarnitine levels between the ME/CFS/SEID patient group and the healthy control group

From: Comparison of serum acylcarnitine levels in patients with myalgic encephalomyelitis/chronic fatigue syndrome and healthy controls: a systematic review and meta-analysis

 

Acylcarnitine levels, ÎĽmol/L (SD)

 

Study

ME/CFS/SEID patient group

Healthy control group

P-value

Kuratsune H, et al. [12]

7.8 (4.1)

12.5 (3.1)

p < 0.001

Kuratsune H, et al. [13]a

M 8.7 (3.3)

No data

p < 0.001

Kuratsune H, et al. [13]a

F 8.4 (4.4)

No data

p < 0.001

Plioplys AV, et al. [14]b

M 9.3 (3.7)

M 13.4 (4.6)

p < 0.00001

Plioplys AV, et al. [14]b

F 8.9 (7.0)

F 15.5 (4.4)

p < 0.00001

Kuratsune H, et al. [15]c

9.6 (2.6)

11.0 (3.4)

p < 0.001

Kuratsune H, et al. [15]d

M 9.7 (2.9)

M 13.4 (4.6)

p < 0.001

Kuratsune H, et al. [15]d

F 9.4 (3.7)

F 15.5 (4.5)

p < 0.001

Soetekouw PM, et al. [16]

11.5 (3.5)

12.1 (3.9)

NS

Jones MG, et al. [17]

7.4 (3.0)

6.5 (3.7)

NS

Reuter SE, et al. [18]

13.8 (3.5)

14.3 (4.1)

NS

  1. aThe data in the upper section are for males and the data in the lower section are for females [13]
  2. bThe data in the upper section are for males and the data in the lower section are for females [14]
  3. cThe data in Swedish [15]
  4. dThe data in the upper section are for Japanese males and the data in the lower section are for Japanese females [15]
  5. ME myalgic encephalomyelitis, CFS chronic fatigue syndrome, SEID systemic exertion intolerance disease, SD standard deviation, M male, F female, NS not significant
Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us